Use of anti-EGFR agents among elderly patients with metastatic colorectal cancer (mCRC).

被引：0
|
作者：
D'Silva, Ashley James
Dotan, Efrat
Kloth, Dwight D.
Beck, Andrew
Cohen, Steven J.
Denlinger, Crystal Shereen
机构：
[1] Temple Univ Hosp & Med Sch, Philadelphia, PA 19140 USA
[2] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 04期
关键词：
D O I：
10.1200/jco.2012.30.4_suppl.657
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
657
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Molecular Predictors of Efficacy to Anti-EGFR Agents in Colorectal Cancer Patients
    Ruzzo, A.
    Graziano, F.
    Canestrari, E.
    Magnani, M.
    CURRENT CANCER DRUG TARGETS, 2010, 10 (01) : 68 - 79
  • [12] Integrating anti-EGFR therapies in metastatic colorectal cancer
    Haraldsdottir, Sigurdis
    Bekaii-Saab, Tanios
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2013, 4 (03) : 285 - 298
  • [13] Best practices in the management of toxicities related to anti-EGFR agents for metastatic colorectal cancer
    Ouwerkerk, Jan
    Boers-Doets, Christine
    EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2010, 14 (04) : 337 - 349
  • [14] Real-world use of anti-EGFR therapy in metastatic colorectal cancer
    Robinson, Hannah Ruth
    Hu, Junxiao
    Balmaceda, Nicole Baranda
    Lentz, Robert William
    Toegel, Emily Baiyee
    Leal, Alexis Diane
    Kim, Sunnie S.
    Messersmith, Wells A.
    Lieu, Christopher Hanyoung
    Davis, S. Lindsey
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [15] Trecc: Re-challenge therapy with anti-EGFR in metastatic colorectal adenocarcinoma (mCRC).
    Karani, Amanda
    Felismino, Tiago
    Diniz, Lara Azevedo
    Macedo, Mariana Petaccia
    Machado, Larissa
    Sales, Diogo De Brito
    Mello, Celso Lopes
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [16] Place of anti-EGFR therapy in older patients with metastatic colorectal cancer in 2020
    Gilabert, Marine
    Ries, Pauline
    Chanez, Brice
    Triby, Simon
    Francois, Eric
    Lievre, Astrid
    Rousseau, Frederique
    JOURNAL OF GERIATRIC ONCOLOGY, 2020, 11 (08) : 1229 - 1236
  • [17] IMMUNOLOGICAL EFFECTS OF DIFFERENT ANTI-EGFR ANTIBODIES IN METASTATIC COLORECTAL CANCER PATIENTS
    Manzoni, M.
    Delfanti, S.
    Rovati, B.
    Brugnatelli, S.
    Ronzoni, M.
    Perfetti, V
    Mariucci, S.
    Loupakis, F.
    Danova, M.
    ANNALS OF ONCOLOGY, 2010, 21 : 33 - 33
  • [18] An Update on the Role of Anti-EGFR in the Treatment of Older Patients with Metastatic Colorectal Cancer
    Rosati, Gerardo
    Montrone, Michele
    Pacilio, Carmen
    Colombo, Alfredo
    Cicero, Giuseppe
    Paragliola, Fernando
    Vaia, Angelo
    Annunziata, Luigi
    Bilancia, Domenico
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (23)
  • [19] MYC gene copy number (GCN) and sensitivity to anti-EGFR monoclonal antibodies in metastatic colorectal cancer (mCRC)
    D'Incecco, Armida
    Landi, Lorenza
    Fountzilas, George
    Kalogeras, Konstantine T.
    Geva, Ravit
    Kako, Severine
    Robb, Caroline M.
    Frattini, Milo
    Rossi, Elisa
    Salvini, Jessica
    Ludovini, Vienna
    Crino, Lucio
    Cappuzzo, Federico
    Varella-Garcia, Marileila
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [20] A synonymous EGFR polymorphism predicting responsiveness to anti-EGFR therapy in metastatic colorectal cancer patients
    Bonin, Serena
    Donada, Marisa
    Bussolati, Gianni
    Nardon, Ermanno
    Annaratone, Laura
    Pichler, Martin
    Chiaravalli, Anna Maria
    Capella, Carlo
    Hoefler, Gerald
    Stanta, Giorgio
    TUMOR BIOLOGY, 2016, 37 (06) : 7295 - 7303
12345